Imperative Care announced that it appointed former Insulet CEO Shacey Petrovic to its board of directors, effective immediately.
Petrovic currently serves on Insulet’s board, having stepped down as CEO just over one year ago. Over three years as Insulet CEO, Petrovic helped the company grow from $2 billion in market cap to more than $20 billion. She’s also on the board of Exact Sciences and Ambu.
She now joins the board of Imperative care, which develops connected technology to treat stroke and other ischemic diseases. The Zoom stroke solution product platform aims to usher in a new era of stroke thrombectomy. It enables fast and consistent treatment, plus improved procedure outcomes. Through reperfusion, physicians can perform fast, effective clot removal in patients with ischemic stroke.
“We have been intentional in assembling the right balance of investors, executives, and industry experiences, on our board, each with their own unique and complimentary expertise and passion in elevating patient care,” said Fred Khosravi, chair and CEO of Imperative Care. “Shacey has dedicated her career to improving care for patients while bringing tremendous value to the clinical community. It is a real privilege to have Shacey serve on our board as we benefit from her vast executive experience. We look forward to her meaningful contributions in delivering on our mission to bring more care to more patients.”
Petrovic also previously served as president and CEO of Clinical Innovations, a maker of devices and diagnostics for women’s health. From 2000 to 2013, she held a number of roles at Hologic and Cytyc (which merged with Hologic in 2007) including VP and GM of Hologic’s GYN surgical products division.
“I am honored to join the Imperative Care board at this exciting time in the company’s history,” said Petrovic. “While many companies claim to put the patient first, Imperative Care has truly built its business around the specific needs of patients affected by stroke and vascular diseases. The company’s commitment to patients is palpable in its leadership and people, and evident in its impact-focused innovations that expand and connect care for patients.”
